Key Investor InformationThis document provides you with key investor information about this fund. It is not marketing material. Theinformation is required by law to help you understand the nature and the risks of investing in this fund. You areadvised to read it so you can make an informed decision about whether to invest. Invesco S&P World Health Care ESG UCITS ETF (the "Fund") A sub-fund of Invesco Markets II plc (the "Umbrella Fund") Acc (ISIN: IE000L4EH2K5) (the "Share Class") The Fund is managed by Invesco Investment Management Limited, part of the Invesco Group.

Objectives and Investment Policy

The Fund is a passively-managed Exchange-Traded Fund ("ETF"), which aims to achieve the net total return of the S&P World ESG Enhanced Health Care

Index (the “Index”)1, less fees, expenses and transaction costs.

In order to achieve the investment objective the Fund will, as far as possible and practicable, hold all the securities in the Index in their respective weightings.

The Fund is an Article 8 Fund (it promotes environmental and/or social characteristics) for the purposes of Regulation (EU) 2019/2088 of the European

Parliament and of the Council of 27 November 2019 on sustainability related disclosures in the financial services sector (“SFDR”).

The Fund may use derivative instruments for the purposes of managing risk, reducing costs or generating additional capital or income. Derivatives on an index

may contain some underlying constituents which may not meet the ESG criteria.

The Fund's shares are listed on one or more Stock Exchange(s). Investors can buy or sell shares daily through an intermediary directly or on Stock Exchange(s)

on which the shares are traded. In exceptional circumstances investors will be permitted to redeem their shares directly from Invesco Markets II plc in accordance

with the redemption procedures set out in the prospectus, subject to any applicable laws and relevant charges.

The Fund’s base currency is USD.

Please note that the Index name was changed from S&P Developed Ex-Korea LargeMidCap ESG Enhanced Health Care Index to S&P World ESG Enhanced

Health Care Index on 27 February 2024.

Dividend Policy: This Share Class does not pay you income, but instead reinvests it to grow your capital, in line with its stated objectives.

Net Asset Value: This is calculated daily and the Fund is open for subscriptions and redemptions on each day the United States Federal Reserve System is

open. Please refer to the prospectus for further information.

The Index: The Index tracks the performance of large and mid-capitalisation Health Care companies in developed markets and seeks to enhance its ESG profile

and reduce its carbon footprint, relative to the S&P World Health Care Index (the “Parent Index”). The Index has been constructed by excluding from the Parent

Index, H56on a quarterly basis, securities that: 1) are involved (according to the Index Provider’s criteria) in business activities in tobacco, controversial weapons,

oil sands, small arms, military contracting and thermal coal, and 2) are classified as Non-Compliant according to the United Nations Global Compact (UNGC)

principles. Securities are also excluded from the Parent Index, on a semi-annual basis, that: 1) do not have a S&P Global ESG Score; (2) do not have carbon

intensity data; (3) have an S&P Global ESG Score that falls within the lowest 20% of ESG scores by stock count of the Parent Index; and (4) have carbon

intensity levels that rank in the worst 10% of companies by free-float market cap per GICS Industry Group of the Parent Index and in the worst 10% of companies

by free-float market cap in the S&P World Index. In addition, securities are also excluded by the Index Provider’s Index Committee if they are deemed to face

potential ESG risk incidents and/or controversial activities. The Index then applies an optimisation approach to re-weight remaining eligible securities which has

the aim of achieving: 1) an uplift in the S&P Global ESG Score; 2) the maximum of either a 30% decrease in carbon intensity relative to the Parent Index or

carbon intensity equivalent to the removal of securities that have carbon intensity levels which rank in the worst 25% of companies per GICS Industry Group and

in the worst 25% of companies in the Parent Index. These securities are then also subject to turnover constraints. The Index is rebalanced on a semi-annual

basis. Involvement and revenue thresholds are defined by the Index provider. Further information in relation to any revenue thresholds and controversy scoring

criteria, can be obtained from the Index provider’s website. Risk and Reward ProfileOther Risks

General Investment Risk: The value of investments, and income from them, Lower Risk Higher Risk can go down as well as up and you may not get back the full amount youinvested.

Securities Lending Risk: The Fund may be exposed to the risk of the Typically lower rewards Typically higher rewards

borrower defaulting on its obligation to return the securities at the end of theloan period and of being unable to sell the collateral provided to it if theborrower defaults.1

2

3

4

5

6

7

Environmental, Social and Governance Risk: The Fund intends to invest insecurities of issuers that manage their ESG exposures better relative to theirpeers. This may affect the Fund’s exposure to certain issuers and cause the  The Share Class is in risk category 6 due to the rises and falls of its price or Fund to forego certain investment opportunities. The Fund may perform

simulated data in the past.

differently to other funds, including underperforming other funds that do not  As the Share Class' risk category has been calculated using historical data, it

seek to invest in securities of issuers based on their ESG ratings.

may not be a reliable indication of the Share Class' future risk profile.

Concentration Risk: The Fund might be concentrated in a specific region or  The risk category may change in the future and is not guaranteed.sector or be exposed to a limited number of positions, which might result in  The lowest category does not mean a risk free investment.greater fluctuations in the value of the Fund than for a fund that is morediversified.

Equity Risk: The value of equities and equity-related securities can beaffected by a number of factors including the activities and results of theissuer and general and regional economic and market conditions. This mayresult in fluctuations in the value of the Fund.

Currency Risk: The Fund’s performance may be adversely affected byvariations in the exchange rates between the base currency of the Fund andthe currencies to which the Fund is exposed.

For more information on risks, please see the Fund prospectus under “RiskFactors”, which is available at etf.invesco.com (select your country andnavigate to the Prospectus on the Documents section on the product page). 1

Investors should note that the Index is the intellectual property of the Index provider. The Fund is not sponsored or endorsed by the Index provider and a full disclaimer can be found in the Fund's prospectus.

1 (2) Charges The charges you pay are used to pay the costs of running the Fund, including the costs of marketing and distributing it. These charges reduce the potential growth of your investment.

One-off charges taken before or after you invest

*Currently, the Fund is not exercising its entitlement to apply entry and exit Entry charge None*charges.

The ongoing charge is based on the fee paid to the Manager. The Manager is Exit charge

None*responsible for discharging from its fee, costs attributable to the Investment

Manager, Administrator, Depositary as well as the Operational Expenses

incurred by the Fund. It excludes portfolio transaction costs except in the case of Charges taken from the Share Class over a yearan entry or exit charge paid by the Fund when buying or selling shares/units in Ongoing charge

0.18%another fund.

Because the Fund is an ETF, investors will typically only be able to buy or sell

shares in the secondary market. Accordingly, investors may incur brokerage and Charges taken from the Share Class under certain specific / or transaction fees in connection with their dealings. Investors may also bear conditionsthe costs of "bid-ask" spreads; meaning the difference between the prices at

which shares can be bought and sold. You should discuss these fees and costs Performance fee

None with your broker before you invest, as they may reduce the amount of your initial

investment and the amount you receive on disposal.

The Fund may engage in securities lending, whereby 90% of the revenues

arising from securities lending will be returned to the Fund and 10% of the

revenues will be retained by the securities lending agent.

For more information on charges, please see the relevant charges section in the

Fund supplement under “General Information Relating to the Fund”, which is

available at etf.invesco.com (select your country and navigate to the Documents

section on the product page). Past Performance% growth The Fund launched in 2023.

2 The Share Class launched in 2023.The base currency of the Fund is USD.Past performance of the Share Class is calculated in USD.Performance is calculated based on the net asset value of the Fund afterdeduction of ongoing charges and is inclusive of gross income reinvested. Any

As this Share Class has no performance data for a entry/exit charges shown are excluded from the calculation.

complete calendar year, there is insufficient data to Past performance is not a guide to future performance.

1provide a useful indication of past performance.

02020

2021

2022

2023 2024

Share Class

1.7

Index1.6 Practical Information Fund Depositary: The Bank of New York Mellon SA/NV, Dublin Branch, Riverside Two, Sir John Rogerson's Quay, Dublin 2, D02 KV60, Ireland. Tax: This Fund is subject to the tax laws and regulations of Ireland. Depending on your home country of residence, this might have an impact on your investment. For further details, please speak to an adviser. Local taxes may have an impact on the personal tax of your investment in the Fund. Additional Information: The share prices are published in USD, on each business day. The prices are available from the administrator during normal business hours and on the following website etf.invesco.com. Find out more: Further information about the Fund can be obtained from the prospectus and latest annual report. This document is specific to the Invesco S&P World Health Care ESG UCITS ETF. However, the prospectus and annual report are prepared for the umbrella fund, Invesco Markets II plc, of which Invesco S&P World Health Care ESG UCITS ETF is a sub-fund. These documents are available free of charge. They can be obtained along with other information, such as share prices, at etf.invesco.com (select your country and navigate to the Documents section on the product page), by emailing investorqueries@invesco.com or by calling +353 1 439 8000. Details of the Manager's remuneration policy are available at www.invescomanagementcompany.ie and a paper copy is available to investors free of charge upon request. Pursuant to Irish law, the assets of this Fund are segregated from other sub-funds in the umbrella fund (i.e. the Fund’s assets may not be used to discharge the liabilities of other sub-funds of Invesco Markets II plc). In addition the assets of this Fund are held separately from the assets of other sub- funds. Subject to satisfying certain criteria as set out in the prospectus, investors may be able to exchange their investment in the Fund for shares in another sub-fund of the Company which is being offered at that time. Invesco Markets II plc may be held liable solely on the basis of any statement contained in this document that is misleading, inaccurate or inconsistent with the relevant parts of the prospectus. This Fund is authorised in Ireland and regulated by the Central Bank of Ireland. Invesco Investment Management Limited is authorised in Ireland and regulated by the Central Bank of Ireland. This key investor information is accurate as at 3 February 2025.

2 (2)